Primaxin

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage.; Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage.

Disponible desde:

Merck Sharp & Dohme (New Zealand) Limited

Designación común internacional (DCI):

Cilastatin sodium 571 mg (Equiv. to 500 mg cilastatin acid. Includes 4.6% overage.)

formulario farmacéutico:

Powder for injection

Composición:

Active: Cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. Includes 4.6% overage. Imipenem monohydrate 560mg equivalent to to 500 mg imipenem. Includes 4.6% overage. Excipient: Sodium bicarbonate

Unidades en paquete:

Ampoule, glass, 5x13ml (Monovial), 5 dose units

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Merck Sharp & Dohme Corp

Resumen del producto:

Package - Contents - Shelf Life: Ampoule, glass, 5x13ml (Monovial) - 5 dose units - 24 months from date of manufacture stored at or below 25°C 4 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Fecha de autorización:

1996-03-20